pdf
Published
2021-04-27
Issue
Section
Pharmacy Practice & Practice-Based Research
License
Copyright (c) 2021 Jennifer Athay Adams, Alex J. Adams, Michael E. Klepser
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of content published in INNOVATIONS in pharmacy belongs to the author(s).
Pharmacist Prescriptive Authority for Acne: An Evidence-Based Approach to Policy
Jennifer Athay Adams
Idaho State University, College of Pharmacy
Alex J. Adams
Idaho State Board of Pharmacy
Michael E. Klepser
Ferris State University, College of Pharmacy
DOI: https://doi.org/10.24926/iip.v12i2.3897
Abstract
The diagnosis of acne is typically straightforward and based on physical signs and symptoms. Some jurisdictions in Canada, the United Kingdom, and United States have enabled a pharmacist treatment model to diagnose and manage patients with mild acne using prescription medications. Studies have found the model to be safe and effective, while simultaneously increasing more timely access to care for patients which may reduce the potential adverse impacts of acne. Further, use of a standardized protocol may alleviate some of the concerns expressed over the model. This paper summarize answers to frequent questions to help policymakers consider the objective evidence for their jurisdiction.
